Artificial Intelligence | News | Insights | AiThority
[bsfp-cryptocurrency style=”widget-18″ align=”marquee” columns=”6″ coins=”selected” coins-count=”6″ coins-selected=”BTC,ETH,XRP,LTC,EOS,ADA,XLM,NEO,LTC,EOS,XEM,DASH,USDT,BNB,QTUM,XVG,ONT,ZEC,STEEM” currency=”USD” title=”Cryptocurrency Widget” show_title=”0″ icon=”” scheme=”light” bs-show-desktop=”1″ bs-show-tablet=”1″ bs-show-phone=”1″ custom-css-class=”” custom-id=”” css=”.vc_custom_1523079266073{margin-bottom: 0px !important;padding-top: 0px !important;padding-bottom: 0px !important;}”]

Biobeat AI Patient Remote Monitoring Platform Receives CE Mark

Remote patient monitoring platform provides ongoing assessment of vital signs and identification of patient impairment in hospital and home settings

Biobeat , a global leader in portable patient remote monitoring solutions for healthcare, today indicated that its portable AI technology patient remote monitoring platform has received the complete CE Mark.

The approval integrates the precise and continuous control of Biobeat chest patch and wrist monitoring devices in relation to the patient’s main vital signs, including blood oxygen saturation, respiratory rate, non-invasive blood pressure cuffless, pulse rate, pulse rate variability, mean arterial pressure, pulse pressure, stroke volume, cardiac output, cardiac index, systemic vascular resistance, and skin temperature. It also includes an electrocardiogram of a lead for the chest monitoring device. Additionally, the approval integrates Biobeat’s wireless capabilities, including its proprietary Gateway (hospital) connectivity tool,

Recommended AI News: Demand Spring Launches Leap Advisory Services

“We are proud to receive the CE Mark for use within the full range of remote patient monitoring capabilities that our portable chest and wrist monitors and AI-enabled patient management tools can provide.” , highlighted Arik Ben Ishay , CEO of Biobeat. “Thanks to this approval, we are promoting our aim to improve care and elevate patient outcomes across the European healthcare continuum, which now includes the new frontier of care – the home.”

Related Posts
1 of 31,999

“With today’s growing need for precise remote patient monitoring technologies, we are excited to receive this approval and consolidate our status as a leading provider of portable monitoring devices and scalable patient management systems for hospital use. and domestic, “explained Dr. Dan J Gelvan, Chairman of Biobeat’s Advisory Board.

Recommended AI News: Mitel Extends Partner First Commitment with Enhanced Global Partner Program

Biobeat’s portable patient monitoring devices use proprietary non-invasive reflective photoplethysmography technology to provide automatic and continuous monitoring of 15 cardiopulmonary vital signs. The wireless solutions are connected to a cloud-based patient management system that provides real-time data and alerts to medical workers, enabling early identification of clinical deterioration. The management platform includes an automated and customizable integrated early warning scoring system, incorporating advanced AI-based algorithms for use in healthcare and analyzing aggregated patient data to more accurately identify deterioration and also provide analysis on the predictions.

Biobeat’s hospital and long-term care management solutions are used today in dozens of medical centers and facilities around the world.

Recommended AI News: RFPIO Launches LookUp, Solution for the Innovation Gap in Sales Content Creation

Comments are closed.